ARDX
NASDAQ · Biotechnology
Ardelyx Inc
$4.00
-0.87 (-17.86%)
Open$4.05
Previous Close$4.87
Day High$4.27
Day Low$3.90
52W High$8.40
52W Low$4.71
Volume—
Avg Volume2.92M
Market Cap1.20B
P/E Ratio—
EPS$-0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+1,078.5% upside
Current
$4.00
$4.00
Target
$47.14
$47.14
$33.22
$47.14 avg
$55.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 501.98M | 253.01M | 556.78M |
| Net Income | -75,924,755 | -34,441,673 | -22,621,785 |
| Profit Margin | -15.1% | -14.4% | -4.1% |
| EBITDA | -46,725,211 | -22,373,462 | -31,484,723 |
| Free Cash Flow | — | — | -21,445,059 |
| Rev Growth | +98.4% | +98.4% | +16.2% |
| Debt/Equity | 1.21 | 1.21 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |